Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OKUR OnKure Therapeutics Inc.
- Stocks
- Healthcare
- NASDAQ: OKUR
Price (delayed)
$2.65
Market cap
$35.8M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$13.94
Enterprise value
-$59.9M
Highlights
OKUR's EPS has surged by 91% year-on-year and by 9% since the previous quarter
The quick ratio has plunged by 63% YoY but it has grown by 4.6% from the previous quarter
The equity is down by 13% since the previous quarter but it is up by 12% year-on-year
OnKure Therapeutics's net income has shrunk by 102% YoY and by 14% QoQ
Key stats
What are the main financial stats of OKUR
Market
Valuations
Earnings
Shares outstanding
13.51M
Market cap
$35.8M
Enterprise value
-$59.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.39
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$61.82M
Net income
-$60.17M
EBIT
-$59.87M
EBITDA
-$59.08M
Free cash flow
-$44.18M
Per share
Balance sheet
Liquidity
EPS
-$13.94
EPS diluted
-$13.94
Free cash flow per share
-$3.29
Book value per share
$6.75
Revenue per share
$0
TBVPS
$7.44
Total assets
$99.88M
Total liabilities
$9.23M
Debt
$955,000
Equity
$90.65M
Working capital
$89.39M
Debt to equity
0.01
Current ratio
11.17
Quick ratio
11
Net debt/EBITDA
1.62
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-64.8%
Return on equity
-69.7%
Return on invested capital
-513%
Return on capital employed
-65.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OKUR stock price
How has the OnKure Therapeutics stock price performed over time
Intraday
-7.02%
1 week
-7.99%
1 month
44.02%
1 year
N/A
YTD
-69.19%
QTD
-38.37%
Financial performance
How have OnKure Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$61.82M
Net income
-$60.17M
Gross margin
N/A
Net margin
N/A
OnKure Therapeutics's operating income has plunged by 102% YoY and by 14% from the previous quarter
OnKure Therapeutics's net income has shrunk by 102% YoY and by 14% QoQ
Price vs fundamentals
How does OKUR's price correlate with its fundamentals
Growth
What is OnKure Therapeutics's growth rate over time
Valuation
What is OnKure Therapeutics stock price valuation
P/E
N/A
P/B
0.39
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
OKUR's EPS has surged by 91% year-on-year and by 9% since the previous quarter
The P/B is 51% less than the last 4 quarters average of 0.8
The equity is down by 13% since the previous quarter but it is up by 12% year-on-year
Efficiency
How efficient is OnKure Therapeutics business performance
OnKure Therapeutics's return on invested capital has shrunk by 178% QoQ
OKUR's ROA has dropped by 117% year-on-year and by 9% since the previous quarter
OKUR's ROE is down by 33% year-on-year and by 11% since the previous quarter
Dividends
What is OKUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OKUR.
Financial health
How did OnKure Therapeutics financials performed over time
The total liabilities has soared by 172% YoY but it fell by 17% QoQ
OnKure Therapeutics's current ratio has plunged by 63% YoY but it has increased by 4.1% from the previous quarter
OKUR's debt is 99% smaller than its equity
The equity is down by 13% since the previous quarter but it is up by 12% year-on-year
OKUR's debt is down by 12% since the previous quarter but it is up by 5% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.